Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar

Conditions:   Drug Resistance;   Plasmodium Falciparum MalariaIntervention:   Drug: First line antimalarial in Myanmar (artemether-lumefrantrine, dihydroartemisinin-piperaquine, and artesunate-mefloquine)Sponsors:   Department of Medical Research, Lower Myanmar;   Kangwon National UniversityCompleted - verified June 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials